Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02258451
Brief Title: Study of Radium-223 Dichloride Versus Placebo and Treatment With Exemestane / Everolimus in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer

First Submitted : September 30, 2014
First Submitted that Met QC Criteria : October 6, 2014
First Posted : October 7, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : April 3, 2019
Last Update Posted : April 4, 2019